Flash e-reader

 Go to e-reader chapter







Data Tables


PDF FormatRequires Adobe Acrobat Reader



View HTMLView PDF

Section VI

6.1aWaiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active Waitlist Patients, 1999 to 2008Table 6.1a (39 k)
6.1a Age
6.1a Blood Type
6.1a Residency
6.1a Gender
6.1a Previous Transplant Any Organ
6.1a Race
6.1a Previous Transplant Same Organ
6.1a Time on Waiting List
6.1bWaiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Inactive Waitlist Patients, 1999 to 2008Table 6.1b (39 k)
6.1b Age
6.1b Blood Type
6.1b Residency
6.1b Gender
6.1b Previous Transplant Any Organ
6.1b Race
6.1b Previous Transplant Same Organ
6.1b Time on Waiting List
6.1cWaiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List All Waitlist Patients, 2000 to 2009Table 6.1c (39 k)
6.1c Mean Age
6.1c Age Group
6.1c Blood Type
6.1c Residency
6.1c Gender
6.1c Previous Transplant Any Organ
6.1c Race
6.1c Previous Transplant Same Organ
6.1c Time on Waiting List
6.2Time to Transplant, 1999 to 2008 New Pancreas Transplant Alone (PTA) Waiting List RegistrationsTable 6.2 (93 k)
6.2 Blood Type
6.2 Age
6.2 Gender
6.2 All Patient Types
6.2 Previous Transplant Any Organ
6.2 Race
6.2 Residency
6.2 State of Center
6.3Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2008 Pancreas Transplant Alone (PTA) Waiting ListTable 6.3 (65 k)
6.3 Age
6.3 Blood Type
6.3 Gender
6.3 Race
6.3 State of Center
6.4Transplant Recipient Characteristics, 1999 to 2008 Pancreas Transplant Alone (PTA) RecipientsTable 6.4 (41 k)
6.4 Age
6.4 Blood Type
6.4 Residency
6.4 Gender
6.4 Race
6.4 Cold Ischemic Time
6.4 Hospitalized at Tx
6.4 Previous Transplant Same Organ
6.4 Previous Transplant Any Organ
6.4 Payment Source
6.5Incidence of Transplant, 1999 to 2008 Pancreas Transplant Alone (PTA) Transplants per 1 Million PopulationTable 6.5 (47 k)
6.6aImmunosuppression Use for Induction, 1999 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6a (32 k)
6.6bImmunosuppression Use for Induction by Discharge Regimen, 2004 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6b (32 k)
6.6cImmunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6c (29 k)
6.6dImmunosuppression Use for Maintenance by Regimen Prior to Discharge, 1999 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6d (29 k)
6.6eImmunosuppression Use for Maintenance Prior to Discharge, 1999 to 2008 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6e (29 k)
6.6fImmunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6f (30 k)
6.6gImmunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6g (30 k)
6.6hPersistency of Discharge Regimen by Follow-up Period, 2003 to 2007 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6h (46 k)
6.6iImmunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) TransplantsTable 6.6i (30 k)
6.7Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1999 to 2007 Rates for Recipients during First Year after Pancreas Transplant Alone (PTA) TransplantationTable 6.7 (99 k)
6.7 Blood Type
6.7 Residency
6.7 Gender
6.7 Race
6.7 Donor Age
6.7 Previous Transplant
6.7 Age
6.7 Cold Ischemic Time
6.7 Hospitalized at Tx
6.7 Level of HLA Mismatch
6.7 State of Center
6.8Adjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 6.8 (37 k)
6.8 Age
6.8 Gender
6.8 Race
6.8 State of Center
6.9Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.9 (22 k)
6.10Unadjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 6.10 (48 k)
6.10 Age
6.10 Blood Type
6.10 Residency
6.10 Gender
6.10 Race
6.10 Center Volume
6.10 Donor Age
6.10 Cold Ischemic Time
6.10 Hospitalized at Tx
6.10 Level of HLA Mismatch
6.10 State of Center
6.11Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.11 (22 k)
6.12Adjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 6.12 (37 k)
6.12 Age
6.12 Gender
6.12 Race
6.12 State of Center
6.13Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.13 (22 k)
6.14Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 YearsTable 6.14 (47 k)
6.14 Age
6.14 Blood Type
6.14 Residency
6.14 Gender
6.14 Race
6.14 Center Volume
6.14 Donor Age
6.14 Cold Ischemic Time
6.14 Hospitalized at Tx
6.14 Level of HLA Mismatch
6.14 State of Center
6.15Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) TransplantsTable 6.15 (22 k)
6.16Prevalence of People Living with a Functioning Transplant at End of Year Pancreas Transplant Alone (PTA) Recipients, 1999 to 2007Table 6.16 (38 k)
6.16 Blood Type
6.16 Residency
6.16 Gender
6.16 Race
6.16 Age
6.16 Hospitalized at Tx
6.16 Previous Transplant Same Organ
6.16 Previous Transplant Any Organ
6.17Transplants by State and Transplant Center, 1999 to 2008 Pancreas Transplant Alone (PTA)Table 6.17 (64 k)